This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to the Monster Stock Market Commentary and join the 2,568 subscribers getting it for FREE every day!
When we look closer we can see on the hourly chart as well.
We can also see how the XLK test and the lows from Monday morning and was able to bounce.
Watch Reading The Market The Fully Loaded Version.
We show you how we break down and the read the markets.
The Litmus Test
Tesla (TSLA) will continue to be our litmus test as to the mood of the market, as there is no other stock that has shown the strength and resolve of Tesla thus in 2017.
We can see once again that the Bulls stepped in a held shares up.
Actually taking the stock up into the close. It continues to show that despite the weakness shown in Tech there is very much a risk-on mentality still embedded within the market.
Free Reads by Mike
Don’t Forget To Get This Quick Lite Version of Reading The Markets Commentary In Your Email
*Charts Provided By Interactive Brokers TWS
Michael Kramer and the clients of Mott Capital Management LLC own shares of TSLA.
Michael Kramer is the Founder and Portfolio Manager of Mott Capital Management LLC, a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendation made during the past twelve months. Past performance is not indicative of future performance.